Table 1 RBM5 expression was correlated with clinicopathological characteristics of gliomas
Characteristics | Total | RBM5 expression | P value | |
|---|---|---|---|---|
Low | High | |||
All cases | 51 | 28 | 23 | |
Age (year) | 0.068 | |||
<60 | 22 | 13 | 9 | |
≥60 | 29 | 15 | 14 | |
Grade | 21 | 9 | 12 | 0.148 |
G1/G2 | 21 | 9 | 12 | |
G3/G4 | 30 | 19 | 11 | |
TNM stage | 0.004 | |||
Early (I/II) | 23 | 8 | 17 | |
Late (III/IV) | 28 | 20 | 8 | |
Sex | 0.405 | |||
Male | 32 | 19 | 13 | |
Female | 19 | 9 | 10 | |